Pages that link to "Q45763459"
Jump to navigation
Jump to search
The following pages link to The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobuli (Q45763459):
Displaying 50 items.
- Antiretroviral therapy for HIV-infected children (Q24247327) (← links)
- A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children (Q24620746) (← links)
- Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants (Q33639399) (← links)
- Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics (Q33668265) (← links)
- Paediatric HIV-1 infection (Q33744042) (← links)
- Diagnosis of HIV infection in children (Q33851980) (← links)
- Viral and immunopathogenesis of vertical HIV-1 infection (Q33851985) (← links)
- Opportunistic infections and other clinical manifestations of HIV disease in children (Q33851989) (← links)
- Medical management of HIV disease in children (Q33851998) (← links)
- Antiretroviral therapy of HIV infection in children (Q33852002) (← links)
- Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions (Q33907111) (← links)
- Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression (Q34076185) (← links)
- Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission (Q34200009) (← links)
- Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy (Q34511504) (← links)
- Viral load as a surrogate end point in HIV disease (Q34533854) (← links)
- Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value (Q34683397) (← links)
- PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS. (Q34760550) (← links)
- The role of protease inhibitor therapy in children with HIV infection (Q34783374) (← links)
- Pediatric HIV infection and treatment (Q34876113) (← links)
- Paediatric HIV in 2002--a treatable and preventable infection (Q34942527) (← links)
- Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group (Q35090926) (← links)
- Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children (Q35149075) (← links)
- Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting (Q35160696) (← links)
- Decline of CD3-positive T-cell counts by 6 months of age is associated with rapid disease progression in HIV-1--infected infants. (Q35170074) (← links)
- Mortality in children and adolescents vertically infected by HIV receiving care at a referral hospital in Vitoria, Brazil (Q35234691) (← links)
- Viral loads in dual infection with HIV-1 and cytomegalovirus (Q35262184) (← links)
- Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. (Q35363070) (← links)
- Impact of antiretroviral protocols on dynamics of AIDS progression markers (Q35567216) (← links)
- Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338). (Q35647376) (← links)
- Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. (Q35828692) (← links)
- Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy (Q35989706) (← links)
- Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy (Q36030494) (← links)
- Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children (Q36049003) (← links)
- Management of antiretroviral therapy in neonates, children, and adolescents (Q36223761) (← links)
- Pediatric human immunodeficiency virus-1 infection (Q36241441) (← links)
- Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children (Q36404594) (← links)
- Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities (Q36557330) (← links)
- Recommendations in pediatric antiretroviral therapy (Q36719674) (← links)
- Pediatric HIV infection: immune and viral evaluation (Q36793648) (← links)
- A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection (Q36975397) (← links)
- Pediatric HIV infection: the state of antiretroviral therapy (Q37124873) (← links)
- Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment (Q37271461) (← links)
- Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality (Q37379992) (← links)
- A novel approach to estimation of the time to biomarker threshold: applications to HIV. (Q39388941) (← links)
- Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma (Q39446413) (← links)
- High Viremia and Wasting Before Antiretroviral Therapy Are Associated With Pneumonia in Early-Treated HIV-Infected Kenyan Infants (Q39535039) (← links)
- Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life (Q41505058) (← links)
- Mucocutaneous Disorders of Pediatric HIV in South West Nigeria: Surrogates for Immunologic and Virologic Indices (Q42267776) (← links)
- Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children (Q43738629) (← links)
- The predictive value of several markers in the progression to acquired immunodeficiency syndrome (Q44270132) (← links)